Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Experimental and Clinical Research Center (ECRC), Max-Delbrück-Centrum for Molecular Medicine, and.
JCI Insight. 2021 Jun 8;6(11):e149228. doi: 10.1172/jci.insight.149228.
Neurodegeneration mediates neurological disability in inflammatory demyelinating diseases of the CNS. The role of innate immune cells in mediating this damage has remained controversial with evidence for destructive and protective effects. This has complicated efforts to develop treatment. The time sequence and dynamic evolution of the opposing functions are especially unclear. Given limits of in vivo monitoring in human diseases such as multiple sclerosis (MS), animal models are warranted to investigate the association and timing of innate immune activation with neurodegeneration. Using noninvasive in vivo retinal imaging of experimental autoimmune encephalitis (EAE) in CX3CR1GFP/+-knock-in mice followed by transcriptional profiling, we are able to show 2 distinct waves separated by a marked reduction in the number of innate immune cells and change in cell morphology. The first wave is characterized by an inflammatory phagocytic phenotype preceding the onset of EAE, whereas the second wave is characterized by a regulatory, antiinflammatory phenotype during the chronic stage. Additionally, the magnitude of the first wave is associated with neuronal loss. Two transcripts identified - growth arrest-specific protein 6 (GAS6) and suppressor of cytokine signaling 3 (SOCS3) - might be promising targets for enhancing protective effects of microglia in the chronic phase after initial injury.
神经退行性变介导中枢神经系统炎症性脱髓鞘疾病的神经功能障碍。先天免疫细胞在介导这种损伤中的作用一直存在争议,有证据表明其既有破坏作用又有保护作用。这使得开发治疗方法的努力变得复杂。对立功能的时间顺序和动态演变尤其不清楚。鉴于多发性硬化症(MS)等人类疾病的体内监测存在局限性,有必要使用动物模型来研究先天免疫激活与神经退行性变的关联和时间。我们使用 CX3CR1GFP/+-敲入小鼠实验性自身免疫性脑脊髓炎(EAE)的非侵入性活体视网膜成像和转录谱分析,能够显示 2 个截然不同的波,其间先天免疫细胞数量明显减少,细胞形态发生变化。第一个波的特征是在 EAE 发病前出现炎症吞噬表型,而第二个波的特征是在慢性期表现出调节性、抗炎表型。此外,第一个波的幅度与神经元丢失相关。鉴定出的两个转录物 - 生长停滞特异性蛋白 6(GAS6)和细胞因子信号转导抑制因子 3(SOCS3)- 可能是增强初始损伤后慢性期小胶质细胞保护作用的有希望的靶点。